Tafenoquine for malaria, vivax

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 6 registered trials.

Why this status

  1. 16 Jun 2016: Trial registered, NCT02802501
  2. 8 Apr 2018: Trial started, NCT02802501
  3. 2 Jun 2020: Trial registered, NCT04411836
  4. 25 Apr 2021: Trial started, NCT04411836
  5. 28 Aug 2024: Trial registered, NCT06575647
  6. 19 Feb 2025: Trial started, NCT06575647

The trials

NCT01290601: Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults

State
Stopped early
Phase
Phase 2
People
70 taking part
Started
15 Sep 2003
Primary completion
10 Jan 2005
Arms
Cohort 1 Tafenoquine, Cohort 2 Tafenoquine
Results
Posted on the registry
Papers
doi:10.1007/s10792-018-1003-2, doi:10.1371/journal.pone.0187376
  1. 10 Jan 2005: Trial terminated
  2. 7 Feb 2011: Trial registered
  3. 25 Jan 2018: Trial results posted

NCT01376167: Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse

State
Completed
Phase
Phase 2
People
851 taking part
Started
24 Apr 2014
Primary completion
18 Nov 2016
Arms
Tafenoquine 50mg, Tafenoquine 100mg, Tafenoquine 300mg, Tafenoquine 600mg, Tafenoquine 300mg (Part 2)
Results
Posted on the registry
Papers
doi:10.1016/s0140-6736(13)62568-4, doi:10.1056/nejmoa1710775, doi:10.1093/infdis/jiv508, doi:10.1111/ijlh.12627, doi:10.1128/aac.00718-15
  1. 20 Jun 2011: Trial registered
  2. 24 Apr 2014: Trial started
  3. 18 Nov 2016: Trial completed
  4. 23 Apr 2018: Trial results posted

NCT02184637: A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate

State
Completed
Phase
Phase 1
People
120 taking part
Started
31 Jul 2014
Primary completion
8 Apr 2015
Arms
Cohort 5 - TQ alone
Results
None posted
Papers
doi:10.1128/aac.01588-16
  1. 9 Jul 2014: Trial registered
  2. 31 Jul 2014: Trial started
  3. 8 Apr 2015: Trial completed

NCT02802501: Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria

State
Completed
Phase
Phase 3
People
150 taking part
Started
8 Apr 2018
Primary completion
19 Aug 2019
Arms
DHA-PQP plus tafenoquine 300 mg single dose
Results
Posted on the registry
Papers
doi:10.1016/s1473-3099(23)00213-x
  1. 16 Jun 2016: Trial registered
  2. 8 Apr 2018: Trial started
  3. 19 Aug 2019: Trial completed
  4. 24 Jul 2020: Trial results posted

NCT04411836: Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine

State
Completed
Phase
Phase 3
People
960 taking part
Started
25 Apr 2021
Primary completion
30 Sep 2024
Arms
TQ Intervention
Results
None posted
Papers
doi:10.1016/s1473-3099(25)00729-7, doi:10.1136/bmjopen-2026-119698
  1. 2 Jun 2020: Trial registered
  2. 25 Apr 2021: Trial started
  3. 30 Sep 2024: Trial completed

How the status changed

  1. 16 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Tafenoquine 100mg, Tafenoquine 300mg, Tafenoquine 300mg (Part 2), Tafenoquine 50mg, Tafenoquine 600mg.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.